What are the benefits of methylphenidate as a treatment for children and adolescents with attention-deficit/hyperactivity disorder?

Affiliations

¹ Centre of Mental Health, Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital of Würzburg, Margarete-Höppel-Platz 1, 97080, Würzburg, Germany. manfred.gerlach@uni-wuerzburg.de.
² Medical Faculty Mannheim, Department of Child and Adolescent Psychiatry, Central Institute of Mental Health, Mannheim, Germany.
³ Departments of Paediatrics and Psychiatry, University of Melbourne, Melbourne, Australia.
⁴ Department of Psychiatry, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
⁵ Centre of Mental Health, Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital of Würzburg, Margarete-Höppel-Platz 1, 97080, Würzburg, Germany.

Editorial

Manfred Gerlach et al. Atten Defic Hyperact Disord. 2017 Mar.

. 2017 Mar;9(1):1-3.

doi: 10.1007/s12402-017-0220-2.

¹ Centre of Mental Health, Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital of Würzburg, Margarete-Höppel-Platz 1, 97080, Würzburg, Germany. manfred.gerlach@uni-wuerzburg.de.
² Medical Faculty Mannheim, Department of Child and Adolescent Psychiatry, Central Institute of Mental Health, Mannheim, Germany.
³ Departments of Paediatrics and Psychiatry, University of Melbourne, Melbourne, Australia.
⁴ Department of Psychiatry, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
⁵ Centre of Mental Health, Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital of Würzburg, Margarete-Höppel-Platz 1, 97080, Würzburg, Germany.

No abstract available

Publication types